When investors hear talk of U.S. cannabis reform, they often look at major Canadian operators. Tilray Brands (NASDAQ: TLRY) frequently finds itself at the center of this conversation. As rumors of Schedule III reclassification circulate, the market tends to price Tilray Brands based on the political winds in Washington. A closer look at the actual revenue engine tells a completely different story.
Right now, Tilray Brands generates no reported U.S. cannabis revenue. Its domestic footprint is built primarily around craft beer, spirits, hospitality, and hemp-based products. Treating the company as a pure-play bet on federal rescheduling ignores the physical operations currently driving Tilray's balance sheet.
